Which hedge funds own SRPT? SAREPTA THERAPEUTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
10 of the hedge funds tracked by WhaleCreep disclosed a position in SRPT (SAREPTA THERAPEUTICS INC) in their Q2 2026 13F filings, worth $118.5m in total. The largest holder by portfolio weight is Casdin Capital at 0.4% of its book. 2 managers opened a new position this quarter: Casdin Capital, Point72 Asset Management LP. 1 exited: RA Capital Management.
10tracked managers holding
2opened this quarter
1exited this quarter
Which hedge funds hold SRPT? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Casdin Capital | Q2 2026 | 0.4% | $8.4m | 470,000 | – | new |
| Marshall Wace | Q2 2026 | 0.0% | $39.6m | 2,206,022 | 204% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $20.2m | 1,121,378 | -33% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $21.4m | 1,193,468 | -2% | reduced |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $9.2m | 510,908 | – | new |
| Bridgewater Associates | Q2 2026 | 0.0% | $2.7m | 152,068 | 13% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $15.9m | 16,897,000 | 0% | held |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $555.8k | 30,928 | -7% | reduced |
| Suvretta Capital Management | Q2 2026 | 0.0% | $321.4k | 17,888 | 0% | held |
| Ancora Advisors | Q2 2026 | 0.0% | $44.9k | 2,500 | -42% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| RA Capital Management | 2.7% | $84.9m |
How has hedge fund ownership of SRPT changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 10 | $118.5m |
| Q1 2026 | 10 | $207.7m |
| Q4 2025 | 5 | $35.9m |
| Q3 2025 | 5 | $121.6m |
| Q2 2025 | 6 | $40.9m |
| Q1 2025 | 8 | $330.6m |
| Q4 2024 | 10 | $569.6m |
| Q3 2024 | 7 | $596.0m |
| Q2 2024 | 7 | $746.8m |
| Q1 2024 | 8 | $556.0m |
| Q4 2023 | 8 | $309.1m |
| Q3 2023 | 10 | $583.6m |
| Q2 2023 | 8 | $438.3m |
| Q1 2023 | 11 | $786.0m |
| Q4 2022 | 12 | $965.4m |
| Q3 2022 | 13 | $896.5m |
Counts every tracked manager that disclosed SRPT in that quarter's filing, including managers that have since stopped filing.